Global myopia and presbyopia treatment market to grow by $9.76b by 2028

It is driven by the rising prevalence of these vision conditions.

The global myopia and presbyopia treatment market is set to expand by $9.76b from 2024 to 2028, with a compound annual growth rate (CAGR) of 9.05%, according to Technavio.

The growth is driven by the rising prevalence of these vision conditions and ongoing innovations in treatment options.

The market is also being fueled by the increasing number of people affected by myopia and presbyopia, particularly among the elderly.

Treatment options such as implantable contact lenses, corneal inlays, and ocular lenses are in demand. Surgical solutions, including LASIK and LASEK, remain popular for myopia correction, while bifocal and multifocal lenses cater to presbyopia.

Glaucoma, cataracts, and digital screen exposure are contributing to rising demand for eye care, with telemedicine and ophthalmic surgeries providing greater access to treatment.

A major barrier to market growth is the high cost of treatments, the report said.

Glasses, contact lenses, and refractive surgeries like LASIK can be expensive, especially with the need for regular replacements or specialised lenses. This financial strain limits accessibility for many patients, preventing early intervention and potentially leading to more expensive treatments down the line. The high cost of advanced technologies also discourages investment from healthcare providers.